Iron Chelating Agents: Clinical Trials

5 trials of Iron Chelating Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 available, 1 recruiting, 1 terminated. 2 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Terminated 1
Phase 41Completed 1

Follow Iron Chelating Agents: new trials by email Literature Review of Iron Chelating Agents trials Research Report on Iron Chelating Agents

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation
Iron chelation, Potato Resistant Starch - Allogeneic Stem Cell Transplant
Phase 2RecruitingUniversity of Michigan Rogel Cancer Center502025-10-152026-07-21
Oral Lactoferrin Versus Iron Supplementation During Pregnancy
Lactoferrin, Iron Supplement, Chelates, Iron - Iron-deficiency
Phase 4CompletedSouth Valley University3002018-01-012018-12-28
Stroke With Transfusions Changing to Hydroxyurea
Red Cell Transfusions, Iron Chelation, Hydroxyurea - Hemochromatosis, Cerebrovascular Accident
Phase 3TerminatedSt. Jude Children's Research Hospital1342006-10-012013-01-18
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Deferasirox - Myelodysplastic Syndrome, Iron Overload
Phase 2CompletedNovartis Pharmaceuticals1762005-07-252021-08-16
Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy
Chelated Iron, Iron sucrose - Iron Deficiency Anemia of Pregnancy
AvailableAssiut University2021-12-09

Conditions studied

Anemia, Iron-Deficiency (1)  ·  Anemia, Sickle Cell (1)  ·  Hematologic Diseases (1)  ·  Hemochromatosis (1)  ·  Iron Overload (1)  ·  Myelodysplastic Syndromes (1)  ·  Stroke (1)

Sponsors

Assiut University (1)  ·  Novartis Pharmaceuticals (1)  ·  South Valley University (1)  ·  St. Jude Children's Research Hospital (1)  ·  University of Michigan Rogel Cancer Center (1)

Countries

United States (3)  ·  Canada (1)  ·  Egypt (1)

Top investigators

Mary Riwes (1)  ·  Mohammad AM Ahmed, MD (1)  ·  Ronald W. Helms, PhD (1)  ·  Russell E. Ware, MD, PhD (1)

Results publications

PMID 19406557, PMID 21826782, PMID 22318199, PMID 22547607, PMID 23861242, PMID 24914136, PMID 32053933

NIH funding

U01HL078787 (1)